On October 11, 2022, Beckman Coulter Diagnostics, a global leader in clinical diagnostics, announced it acquired StoCastic, a leading artificial intelligence company that provides evidence-based decision support for hospital emergency departments (ED). StoCastic’s TriageGo will be a cornerstone of Beckman Coulter’s artificial intelligence (AI) enabled Clinical Decision Support (CDS) portfolio, a growing field that aims to further improve patient care by leveraging data-driven insights to clinicians and optimize clinical decision making. The transaction was completed on October 3, 2022, and all associates of StoCastic have joined Beckman Coulter’s Clinical Decision Support business.
Wilson Sonsini Goodrich & Rosati represented Beckman Coulter in the transaction. The team includes:
M&A
Rich Mullen
Brian Chan
Jen Yamin
Technology Transactions
Amy Foust
Tony Nguyen
Privacy and Cybersecurity
Matt Staples
Daniel Chen
Dantam Le
Employee Benefits and Compensation
Sriram Krishnamurthy
Matthew Norgard
Real Estate
James McCann
For more information, please see the press release.